Recombinant Human TPBG/5T4 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00563P-100UG

Human TPBG on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human TPBG/5T4 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00563P-100UG
Collections: High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human TPBG/5T4 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Ser32-Ser355. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q13641 |
Target Symbol | TPBG/5T4 |
Species | Human |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Ser32-Ser355 |
Mol. Weight | The protein has a predicted MW of 62.08 kDa. Due to glycosylation, the protein migrates to 75-105 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human TPBG, hFc Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Biotinylated Anti-TPBG Antibody, hFc Tag with the EC50 of 26.8ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | The oncofetal tumor-associated antigen 5T4 (TBGP) has been linked with CSC properties in several different malignancies. 5T4 has functional attributes that are relevant to the spread of tumors including through EMT, CXCR4/CXCL12, Wnt, and Hippo pathways which may all contribute through the mobilization of CSCs. |